Serum total l-carnitine levels in non-obese women with polycystic ovary syndrome
BACKGROUND Carnitine plays essential roles in energy production, oxidative stress and glucose metabolism. This study was planned to determine serum total l-carnitine levels in non-obese women with polycystic ovary syndrome (PCOS). METHODS There were 27 non-obese women with PCOS and 30 healthy, age-...
Saved in:
Published in | Human reproduction (Oxford) Vol. 23; no. 7; pp. 1602 - 1606 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford
Oxford University Press
01.07.2008
Oxford Publishing Limited (England) |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | BACKGROUND Carnitine plays essential roles in energy production, oxidative stress and glucose metabolism. This study was planned to determine serum total l-carnitine levels in non-obese women with polycystic ovary syndrome (PCOS). METHODS There were 27 non-obese women with PCOS and 30 healthy, age- and body mass index (BMI) matched controls were evaluated in this controlled clinical study. Serum lipid sub-fractions, fasting glucose, insulin and other hormones (gonadotrophins, androgens) and total l-carnitine levels were measured. Homeostasis model assessment (HOMA-IR) was used to estimate insulin resistance. RESULTS The women with PCOS had significantly higher serum dehydroepiandrosterone sulfate, total testosterone, free androgen index (FAI), luteinizing hormone (LH), low-density lipoprotein (LDL) cholesterol, non-high density lipoprotein (HDL) cholesterol, fasting insulin levels and HOMA-IR measurement and LH/FSH ratios than healthy women. However, total l-carnitine and sex hormone-binding globulin (SHBG) levels were significantly lower in women with PCOS. l-Carnitine level was negatively correlated with FAI, but positively correlated with SHBG. Multiple regression analysis revealed that SHBG was a strong predictor of serum total l-carnitine level. CONCLUSIONS Decreased total l-carnitine levels may be associated with hyperandrogenism and/or insulin resistance in non-obese women with PCOS. Long-term studies are needed to evaluate carnitine metabolism in PCOS, especially with regard to the molecular basis. |
---|---|
Bibliography: | istex:FD757AD418006E0ED991636EDDB654CCFAE2D68A ArticleID:den109 ark:/67375/HXZ-C957PVXS-Z ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0268-1161 1460-2350 |
DOI: | 10.1093/humrep/den109 |